I. Delucca

发表

Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors.

D. Cheney, C. Weigelt, Yan Zou, 2013, Bioorganic & medicinal chemistry letters.

Neutral macrocyclic factor VIIa inhibitors.

Brandon L. Parkhurst, Wen Jiang, D. Cheney, 2017, Bioorganic & medicinal chemistry letters.

Discovery of Phenylglycine Lactams as Potent Neutral Factor VIIa Inhibitors.

Brandon L. Parkhurst, Wen Jiang, D. Cheney, 2016, ACS medicinal chemistry letters.

Design, synthesis and structure-activity relationship studies of novel 4,4-bis(trifluoromethyl)imidazolines as acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors and antihypercholesterolemic agents.

J. Billheimer, H. Y. Li, P. Gillies, 1997, Bioorganic & medicinal chemistry.

Novel 4,4-bis(trifluoromethyl) imidazolines as stereospecific and orally active acyl coa: Cholesterol acyltransferase (ACAT) inhibitors and antihypercholesterolemic agents

J. Billheimer, P. Gillies, I. Delucca, 1996 .

Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors.

D. Cheney, A. Rendina, R. Wexler, 2015, Journal of medicinal chemistry.

Topical antiinflammatory dehydroabietylamine derivatives. IV

Wendell W. Wilkerson, William Galbraith, Indawati DeLucca, 1993 .

A FACILE SYNTHESIS OF 4,4-BIS(TRIFLUOROMETHYL)-IMIDAZOLINES VIA A NOVEL OXIDATIVE IMIDAZOLE REARRANGEMENT

I. Delucca, G. A. Boswell, Hui‐Yin Li, 1996 .

An Unusual Trifluoromethyl Elimination Reaction from the 4,4-Bis(trifluoromethyl)-5-hydroxyimidazoline Ring System.

I. Delucca, G. A. Boswell, Hui‐Yin Li, 1997, The Journal of organic chemistry.

Antiinflammatory β-benzeneethanamines. III

J. Kerr, W. W. Wilkerson, I. Delucca, 1993 .

Imidazolinones as nonpeptide angiotensin II receptor antagonists

P. Timmermans, R. Wexler, A. Chiu, 1994 .

Antiinflammatory phospholipase-A2 inhibitors. I

B. Jaffee, Wendell W. Wilkerson, R. Harris, 1991 .